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Resumo
A perturbação de ingestão alimentar evitante/restritiva (ARFID) é uma das perturbações alimentares menos compreen‑
didas, não havendo guidelines para o seu tratamento. Os doentes com ARFID frequentemente apresentam perturbações 
psiquiátricas comórbidas. As perturbações da alimentação e ingestão podem apresentar pancitopénia associada a um mau 
estado nutricional. O nosso objetivo é apresentar um caso clínico de pancitopénia num doente com ARFID. Trata ‑se 
de um homem de 20 anos internado por pancitopénia. Foi feito o diagnóstico de ARFID em comorbilidade com 
perturbação de ansiedade generalizada. Foi implementada terapia cognitivo comportamental, e após seis meses houve 
uma melhoria na ingestão alimentar, com maior diversidade de alimentos ingeridos. Este é o primeiro caso 
documentado de ARFID com pancitopénia. É crucial uma abordagem multidisciplinar, não só para um diagnóstico 
correto, mas também para o tratamento adequado com prevenção de recaídas.
Abstract
Avoidant restrictive food intake disorder (ARFID) is one of the least clearly understood feeding and eating disorders, and 
there are no guidelines for its treatment. Patients with ARFID often present comorbid psychiatric disorders. The feeding 
and eating disorders can present with pancytopenia associated with poor nutritional status. Our aim is to present a clinical 
case of pancytopenia in a patient with ARFID. The case concerns a 20 ‑year ‑old man hospitalized with pancytopenia. It 
was diagnosed ARFID and comorbid generalized anxiety disorder. Cognitive behavior therapy was implemented, 
and after six months there was an improvement in the feeding behavior, with greater diversity of ingested food and 
remission of pancytopenia. This is the first documented case of ARFID with pancytopenia. A multidisciplinary 
approach is crucial not only for the correct diagnosis, but also for the effective treatment with relapse prevention.
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The Diagnostic and Statistical Manual of Mental Disorders, 
Fifth Edition (DSM ‑5),1 includes avoidant restrictive food 
intake disorder (ARFID) as an eating or feeding distur‑
bance manifested by a persistent failure to meet appropri‑
ate nutritional and/or energy needs, resulting in at least one 
of the following: significant weight loss, significant nutri‑
tional deficiency, dependence on nutritional supplements, 
and/or interference with psychosocial functioning.2–6 
Based on clinical presentations, DSM ‑5 proposes three 
ARFID subgroups, including an apparent lack of interest 
in eating, sensitivity to the sensory characteristics of food, 
and fear of aversive consequences of eating.5,7 Children 
and adolescents within the first two ARFID subgroups are 
usually younger, include a greater proportion of boys4,7,8 
and a longer duration of illness.8 ARFID in young children 
persist into later childhood, adolescence, and even adult‑
hood.5,6,8 The etiology and management are poorly under‑
stood7 and there are no clear treatment guidelines.4 ARFID 
has a great likelihood of comorbid psychiatric illness, such 
as obsessive ‑compulsive disorder,9 anxiety disorders,3,4,9 
depressive disorder,4 neurodevelopmental disorder.3,4,7,9
Eating disorders can present with pancytopenia,10 associ‑
ated with serious vitamin deficiencies, mimicking hema‑
tological disorders. We report a case of pancytopenia in a 
patient with ARFID and relatively poor nutritional status.
CLINICAL CASE
A 20 ‑year ‑old old single man was admitted to the emergen‑
cy department in May 2019, with fatigue and malnutrition. 
He reported that he never ate any vegetable, meat, or fish, 
having refused to eat other food because he did not know 
the taste or texture. During 2019, he reduced the amount 
of food intake with the intention of losing weight, having 
lost 10 kg. Previously, his weight was 73 kg. There was no 
disturbance in body image or fear of gaining weight. On 
admission, the body mass index was 20.6 kg/m2. Dietary 
assessment history revealed that at 4 years of age he only 
ate rice, fried potato chips, pasta, bread, milk and some‑
times apple. At the age of 10, started to refuse milk and 
fruit. At the age of 15, was diagnosed with anemia, and 
was treated with iron and vitamin B12. Family described 
picky eating habits since childhood. He denied laxative 
use, diet pills or diuretics. There was a personal history of 
anxiety disorder, with psychotherapy from the age of 4 to 
14. No other relevant personal or family history.
Laboratory findings revealed pancytopenia with anemia 
and vitamin B12 deficiency (hemoglobin 5.3 g/dL; white 
blood cell count 2.600 cells/μL; thrombocytopenia 60.000 
cells/μL; vitamin B12 undetectable). Bone marrow aspira‑
tion was normal. Acute leukemia and other oncologic dis‑
eases were excluded. He was hospitalized in the Medicine 
Department with necessity for blood transfusions and B12 
vitamin and folic acid supplements. He exhibited emo‑
tional immaturity and significant difficulties managing 
interpersonal and environmental stressors throughout his 
hospital stay. He was observed by Liaison Psychiatry and 
diagnosed with ARFID and comorbid generalized anxiety 
disorder, with extreme sensitivity to texture or taste of cer‑
tain food and fear of aversive consequences of new eating 
habits but recognizing the consequences of malnutrition. 
During hospitalization, he started cognitive behavioral 
therapy (CBT), with reduction in anxiety regarding eating, 
and he was also referred to a nutritional therapist, but he 
could not change the feeding pattern. Despite this, given 
that the blood findings slightly improved, the final diagno‑
sis was pancytopenia secondary to malnutrition.
After discharge, he maintained oral vitamin supplemen‑
tation and CBT, with decrease fear of trying unfamiliar 
foods. It was not prescribed psychopharmacological 
treatment. He accepted a structured nutritional plan with 
gradual exposure ‑based therapy (he tried a “new” food 
every 2 weeks). Gradually he started to eat other foods, 
and six months later he ate some meat (chicken and pork), 
eggs, fruits (apple and orange) and some vegetables (carrot 
and cabbage). His complete blood count was normal at this 
stage, with pancytopenia remission and was discharged 
from the hematology consultation.
DISCUSSION
The nutritional consequences of ARFID remain poorly de‑
scribed. Some papers reported weight loss,2,4,8,11 microcytic 
anemia3 and one describes a case of subacute combined 
degeneration of the spinal cord due to multiple vitamin 
deficiencies.12 Although there is a case in the literature of 
anorexia nervosa with pancytopenia,10 there are no other 
case reports describing ARFID with pancytopenia second‑
ary to malnutrition.
In this case report, pancytopenia was not a comorbidity, 
but a consequence of ARFID secondary to malnutrition. 
The food avoidance exhibited by the patient since child‑
hood, with extreme sensitivity to texture or taste of certain 
food and fear of aversive consequences of new eating 
habits, may be driven partly by anxiety, and may function 
to relieve anxiety, thus negatively reinforcing the avoidant 
behaviour.9 This case is consistent with the prevalence of 
anxiety disorder among patients with a “selective eating” 
profile that persists since childhood into adulthood.13,14
Restrictive behaviour can induce specific deficiencies re‑
lated to the nature of the excluded foods.3 
Treatment for ARFID must take into account the extent 
of nutritional compromise, impact on weight, and inter‑
ference with social and emotional development or func‑
tioning, with associated distress or impairment.8 Eating 
disorders are accompanied by anxiety, therefore it seems 
plausible to treat ARFID with similar techniques as used 
for anxiety disorders.5,15 Recently, case reports/series have 
suggested promising approaches for older children, ado‑
lescents and adults with ARFID, using either family ‑based 
treatment (FBT), cognitive behavioral therapy, or other 
novel approaches.11
There are no psychopharmacological guidelines for AR‑
FID. Benzodiazepines can be considered for anxious pa‑
tients in the short term.4 In some severe cases, olanzapine3 
or mirtazapine4 have been proposed. Selective Serotonin 
Reuptake Inhibitors are not a good option, because of their 
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potential side ‑effects, and could exacerbate the feeding 
issues.2,4
In the case described, no psychopharmacological ther‑
apeutics were introduced because there was a decrease 
in anxiety with CBT and the patient accepted a diet plan 
with progressive introduction of food and pancytopenia 
remission.
In conclusion, this is the first documented case of ARFID 
with pancytopenia and an accurate differential diagnosis 
of pancytopenia is essential for the most appropriate treat‑
ment.4 Like traditional eating disorders, ARFID presenta‑
tion includes chronic restrictive eating behaviors resulting 
in malnutrition and serious medical complications.7 A 
multidisciplinary approach is required,4 not only for the 
correct diagnosis, but also for the effective treatment with 
relapse prevention, including medical monitoring, nutri‑
tional intervention, and psychological therapy.8
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